Pharmacogenomics Hub in a strengthened IMGGE

Projektinformationen

PharmGenHUB

ID Finanzhilfevereinbarung: 101059870

DOI

10.3030/101059870

Projekt abgeschlossen

EK-Unterschriftsdatum 6 April 2022

Startdatum 1 Juli 2022

Enddatum 30 Juni 2025

Finanziert unter

• Widening participation and spreading excellence

Gesamtkosten

€ 1 339 250,00

EU-Beitrag

€ 1 339 250,00

Koordiniert durch

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Serbia

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (8)

First report on the bioinformatics trainings at UPAT
Strengthened transferable and soft skills of the IMGGE staff
Setting up a RMU at IMGGE

RMU will be set up at the kickoff meeting M1 by appointing staff from IMGGE

First report on the human iPSC-based model system trainings at UNITS

First report on the human iPSCbased model system trainings at UNITS

Plan for dissemination, exploitation and communication (kick-off meeting)

Initial plan for dissemination exploitation and communication

Kick-off meeting report and naming the Project Management Board and Advisory Board

Kickoff meeting report and naming the Project Management Board and Advisory Board

First report on the advanced statistics trainings at UL
Data management plan (Kick-off meeting)

Data management plan initial following Kickoff meeting

Websites, patent fillings, videos etc. (2)

Interactive web site

Interactive web site will be created where information regarding the aims of the Project progress in achieving goals and relevant supporting will be available at all times and updated monthly from month 6 The web site will be also accessible through IMGGE web site wwwimggebgacrs and will be bilingual Serbian and English languages

Leaflets containing information on significance and clinical use of pharmacogenomics markers.

Leaflets containing information on significance and clinical use of pharmacogenomics markers Three leaflets are planned

Veröffentlichungen

Peer reviewed articles (3)

Comprehensive pharmacogenomics profiling of the Serbian population

Autoren: Marina Jelovac, Djordje Pavlovic, Biljana Stankovic, Nikola Kotur, Bojan Ristivojevic, Sonja Pavlovic, Branka Zukic
Veröffentlicht in: Frontiers in Pharmacology, Ausgabe 16, 2025, ISSN 1663-9812
Herausgeber: Frontiers Media SA
DOI: 10.3389/FPHAR.2025.1553536

The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity

Autoren: Debora Curci, Biljana Stankovic, Nikola Kotur, Letizia Pugnetti, Vladimir Gasic, Maurizio Romano, Branka Zukic, Giuliana Decorti, Gabriele Stocco, Marianna Lucafò, Sonja Pavlovic
Veröffentlicht in: Frontiers in Pharmacology, Ausgabe 15, 2024, ISSN 1663-9812
Herausgeber: Frontiers Media SA
DOI: 10.3389/FPHAR.2024.1448136

The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress

Autoren: van Schaik RH, Manolopoulos VG, Daly AK, Niemi M, Zukic B, Patrinos GP, Primorac D, Swen JJ, Ingelman-Sundberg M, Morris T, Molden E, Müller D, Pavlovic S, Russmann S, Ansari M, Henricks LM, den Broek WV, Florindi F, Bozina N, Akin D, Christrup L, Llerena
Veröffentlicht in: Pharmacogenomics, Ausgabe 24(5), 2023, ISSN 1462-2416
Herausgeber: Ashley Publications Ltd.
DOI: 10.2217/PGS-2023-0013